Ticamet

Indication

Ticamet HFA inhaler is indicated for the regular treatment of asthma where the use of a combination product (long-acting beta-2 agonist and inhaled corticosteroid) is appropriate:

• Patients not adequately controlled with inhaled corticosteroids and “as-needed” inhaled short-acting beta-2 agonists

• Patients already adequately controlled on both inhaled corticosteroids and long-acting beta-2 agonists